{"DataElement":{"publicId":"3679673","version":"1","preferredName":"Person Cytochrome P450 3A4 Inhibition Agent Eligibility Determination End Date","preferredDefinition":"the last date an agent was received that inhibits the human CYP3A4 gene.","longName":"CYP3A4INHBTRDT","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"3245727","version":"1","preferredName":"Person Cytochrome P450 3A4 Inhibition Agent Eligibility Determination","preferredDefinition":"information related to criteria to determine eligibility of patients for medical care programs and services based on having received an agent that inhibits human CYP3A4 Gene.","longName":"2236731v1.0:3245725v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3245728","version":"1","preferredName":"Cytochrome P450 3A4 Inhibition Agent Eligibility Determination","preferredDefinition":"Induced primarily in liver by glucocorticoids, drugs, pesticides, and carcinogens and encoded by human CYP3A4 Gene (Cytochrome P450 IIIA Subfamily), Cytochrome P450 3A4 is a 502-amino acid 57.3-kD membrane-bound ER heme-thiolate monooxygenase. CYP3A4 is involved in an NADPH-dependent electron transport pathway and phase I oxidative metabolism of carcinogens, steroids, fatty acids, and xenobiotics, as well as bioactivation of aflatoxin B(1) to a genotoxic derivative. Activity seems a key predictor of drug responsiveness and toxicity. (from LocusLink, Swiss-Prot, OMIM, and NCI):The interference with or prevention of an action or response even though the stimulus for that action or response is present.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI):Criteria to determine eligibility of patients for medical care programs and services.","longName":"C17573:C42791:C1708:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytochrome P450 3A4","conceptCode":"C17573","definition":"Cytochrome P450 3A4 (503 aa, ~57 kDa) is encoded by the human CYP3A4 gene. This protein is involved in the oxidation of steroids, fatty acids and xenobiotics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Inhibition","conceptCode":"C42791","definition":"The interference with or prevention of an action or response even though the stimulus for that action or response is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A627B9D4-1A02-9F39-E040-BB89AD433981","latestVersionIndicator":"Yes","beginDate":"2011-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-20","modifiedBy":"ONEDATA","dateModified":"2011-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A627E516-5EDB-A09C-E040-BB89AD4360A2","latestVersionIndicator":"Yes","beginDate":"2011-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188674","version":"1","preferredName":"End Date","preferredDefinition":"The date on which an observation or an event ended.","longName":"END_DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"mm/dd/yy","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184285","version":"1","preferredName":"Date","preferredDefinition":"A particular day specified as the time something has, or will, happen.","longName":"Date","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1B1A-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E53ADB93-5DF7-315A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"KNABLEJ","dateModified":"2017-08-23","changeDescription":"8/23/17 jk transferred context, cap first letter in def, and added CSI, registration status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CYP3A4INHBTRDT","type":"USED_BY","context":"Alliance"},{"name":"CMSTDAT_CYPINH","type":"OID, Alliance","context":"Alliance"}],"ReferenceDocuments":[{"name":"CYP3A4 inhibitor therapy end","type":"Preferred Question Text","description":"CYP3A4 inhibitor therapy end date","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Last day of CYP3A4 inhibitor treatment","url":null,"context":"Alliance"},{"name":"CRF Text2","type":"Alternate Question Text","description":"last day of strong inhibitor of CYP3A4","url":null,"context":"Alliance"},{"name":"CRF Text3","type":"Alternate Question Text","description":"last day of strong CYP3A4 inhibitor","url":null,"context":"Alliance"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Last CYP3A4 Inhibitor Treatment Date","url":null,"context":"Alliance"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Drug discontinuation date","url":null,"context":"Alliance"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"last day of strong CYP3A4 inhibitor treatment","url":null,"context":"Alliance"},{"name":"CRF Text 7","type":"Alternate Question Text","description":"Strong CYP3A4 inhibitor treatment completion date","url":null,"context":"Alliance"},{"name":"CRF Text 8","type":"Alternate Question Text","description":"If Yes, Strong CYP3A4 inhibitor treatment Completion Date","url":null,"context":"Alliance"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4EC0E5C-9246-E2CC-E040-BB89AD435DB0","latestVersionIndicator":"Yes","beginDate":"2013-02-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-04","modifiedBy":"ZHWENDY","dateModified":"2024-01-18","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":"9/1/2023: added AQT per cadsr0002804.wz","unresolvedIssues":null,"deletedIndicator":"No"}}